In our cohort, the most common specific CHEK2 variant was 1100delC which has been reported to be associated with increased risk of death from breast cancer, increased risk of male breast cancer, and an increased risk of second breast cancer15, 16as well as an increased risk of estrogen receptor (ER)‐positive breast cancer.15, 17. Here, CHEK2 is linked to breast cancer.